Amneal Pharmaceuticals (AMRX) Gross Margin (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Gross Margin of 44.31% for Q1 2026, up 751.0% year-over-year from 5.21% in Q1 2025, and up 21.4% quarter-over-quarter from 36.5% in Q4 2025.
Amneal Pharmaceuticals (AMRX) Gross Margin (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Gross Margin history runs 10 years deep, the most recent figure standing at 44.31% for Q1 2026.
- In Q1 2026, Gross Margin rose 751.0% year-over-year to 44.31%; the TTM figure through Mar 2026 stood at 38.66% (up 197.0% YoY), while the FY2025 annual figure was 36.88%, up 36.0% from the prior year.
- Gross Margin for Q1 2026 stood at 44.31%, up from 36.5% in the prior quarter.
- The five-year high for Gross Margin was 44.31% in Q1 2026, with the low at 13.61% in Q4 2022.
- The 5-year median for Gross Margin is 35.98% (2024), against an average of 33.41%.
- The sharpest annual moves came in 2022 and 2023: Gross Margin tumbled 4460 bps in 2022, then jumped 4438 bps in 2023.
- Amneal Pharmaceuticals' Gross Margin stood at 13.61% in 2022, then soared by 326 bps to 30.77% in 2023, then climbed by 17 bps to 35.98% in 2024, then increased by 1 bps to 36.5% in 2025, then rose by 21 bps to 44.31% in 2026.
- Business Quant data shows AMRX's Gross Margin at 44.31% in Q1 2026, 36.5% in Q4 2025, and 34.92% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.72 Bn | 5.59 Bn | 334.51 Mn | 42.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.01% |
| Mar 31, 2026 | 44.31% |
| Dec 31, 2025 | 36.50% |
| Sep 30, 2025 | 34.92% |
| Jun 30, 2025 | 39.51% |
| Mar 31, 2025 | 36.80% |
| Dec 31, 2024 | 35.98% |
| Sep 30, 2024 | 38.37% |
| Jun 30, 2024 | 35.62% |
| Mar 31, 2024 | 36.11% |
| Dec 31, 2023 | 30.77% |
| Sep 30, 2023 | 37.50% |
| Jun 30, 2023 | 36.73% |
| Mar 31, 2023 | 31.96% |
| Dec 31, 2022 | -13.61% |
| Sep 30, 2022 | 35.60% |
| Jun 30, 2022 | 35.85% |
| Mar 31, 2022 | 35.08% |
| Dec 31, 2021 | 30.99% |
| Sep 30, 2021 | 37.55% |